TCR2 Therapeutics
BioTech/Drugs - Cambridge, MA, US
TCR2 Therapeutics Employees
TCR2 Therapeutics Senior Management
TCR2 Therapeutics Details
TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.
TCR2 Therapeutics Technologies
Email Providers
Outlook
CMS
WP Engine
Other
Mobile Friendly
Hosting
Google Cloud Hosting
Search Marketing
Adobe Marketing Cloud